Management Forum Logo

Presented by
Management Forum

Understanding Pharmacovigilance Regulations in APAC Training Course

Countries to include China, Singagpore, Malaysia, Philippines and Australia

Pharmacovigilance regulations in Asia are dynamic and fast-changing. As the Asia-Pacific region becomes increasingly important for pharmaceutical companies, it's vital to ensure compliance and safety by staying informed of the latest regulatory developments.

8-9 July 2024
+ 8-9 October 2024 »

from £549

Need help?  Enrol or reserve

Overview

Pharmacovigilance regulations in Asia are dynamic and fast-changing. As the Asia-Pacific region becomes increasingly important for pharmaceutical companies, it's vital to ensure compliance and safety by staying informed of the latest regulatory developments.

This two-day pharmacovigilance webinar has been designed to provide a comprehensive guide to compliance in this geographic region. It will provide an ideal opportunity to keep up-to-date with the latest Good Pharmacovigilance Practices (GVP) and post market PV operations in China, and post-market pharmacovigilance regulations in Singapore, Malaysia, the Philippines, and Australia.

Our panel of experts from this region will provide an overview of Good Pharmacovigilance Practices and discuss pharmacovigilance-related requirements. Gain key takeaways to better understand the new GVP regulations and pharmacovigilance compliance in these countries.

Don't miss this opportunity to learn from industry leaders and enhance your knowledge of dynamic and fast-changing regulations in Asia, and the growing market in the Asia-Pacific region.

This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.

Benefits of Attending

  • Gain a comprehensive overview of Pharmacovigilance regulations in China, Singapore, Malaysia, the Philippines, and Australia
  • Stay updated with the latest Pharmacovigilance regulations in these countries
  • Enhance your Pharmacovigilance-related knowledge and skills
  • Understand the local requirements for RPPV (QPPV), PSMF, RMP, and other related regulations in each of these countries

Who Should Attend

This webinar is intended for anyone involved in and interested in Good Pharmacovigilance Practices (GVP) and the daily practice of pharmacovigilance, including:

  • Professionals working in pharmacovigilance departments
  • Drug safety specialists
  • Adverse reaction monitoring professionals
  • R&D professionals
  • Regulatory affairs specialists
  • Pharmaceutical physicians

Enrol or reserve

The Understanding Pharmacovigilance Regulations in APAC course will cover:

Pharmacovigilance in China - GVP Overview

An Overview of China Pharmacovigilance

  • Annual report of China national ADR monitoring
  • China PV concept
  • PV development in China
  • Competent authorities
  • National systems introduction

China GVP 2021 Introduction and Requirements

  • Quality management: PV system, quality objective, QA system, QC indicators
  • Organizational structure, personnel, resources: RPPV (QPPV), PV department
  • Monitor and report: data collection, ICSR case processing, report submission, literature search
  • Risk identification and evaluation: incl. PSUR/PBRER, post marketing safety study
  • Risk control: risk control measures, risk communication, PV plan (RMP)
  • Documentation, record and data management: incl. PSMF
  • PV annual report
  • Brief introduction of clinical PV requirements

Best Practices for Compliance with China's GVP Requirements

  • 4 key tips
  • 4 key pitfalls
  • Authority inspection  
  • Q&A

Post-Market PV Operation

PV Operation - Individual Case Study Reports (ICSR)

  • ICSR Overview
  • Adverse Events Collection, Processing, and Submission to Regulatory Authorities
  • National ADR Monitoring System Report Submission demonstration

Periodic Safety Update Report (PSUR)/PBRER

  • Structures and contents
  • Timelines

Pharmacovigilance Regulations in Singapore, Malaysia, Philippines and Australia

Pharmacovigilance Regulations in Australia

  • Introduction to Pharmacovigilance in Australia
  • Pharmacovigilance system
    • QPPVA and Australian PV contact person
    • APSS (Australian Pharmacovigilance System Summary)
    • DAEN Database
  • Reporting of Adverse Reactions
    • Timeframes, Reporting requirements.
  • Significant safety issues
  • Risk Management Plan (RMP) and Australia Specific Annex (ASA)
    • Submission requirements, Documents, Risk Minimisation activities
  • Periodic Safety Update Reports (PSUR)
    • Reporting requirements, Format & contents
  • Actions taken by other HA’s.
  • PV inspections and Pharmacovigilance inspection program (PVIP)

Pharmacovigilance Regulations in Malaysia

  • Introduction to Pharmacovigilance in Malaysia and Legal Basis
  • Pharmacovigilance system
    • Responsibilities of MAH, Responsible Person for PV (RPPV), Record Retention
  • Managing ADR/AEFI reports
    • Collection, Validation of reports, ADR reporting systems, Timeframes, and Submission requirements
  • Periodic Benefit-Risk Evaluation (PBRERs)
    • Overview, Format & content of PBRER, Submission requirements, Annexes
  • Risk Management Plans (RMPs)
    • Objective, Structure, Submission requirements, Risk Minimisation activities
  • Pharmacovigilance System Master File (PSMF)
    • Objective, Format & content of PSMF, Annexes
  • Emerging Safety issues, Safety evaluation by NPRA, Safety communications
  • Audits & Inspections

Pharmacovigilance Regulations in Singapore

  • Introduction to Pharmacovigilance in Singapore and Legal Basis
  • Responsibilities of the Company
  • Adverse Event reporting
    • Reporting requirements, Records, Special situation reporting
  • Risk Management Plans
    • Submission requirements, Documents, Risk Minimisation activities
  • Periodic Benefit-Risk Evaluation (PBRERs)
    • Reporting requirements
  • Actions taken by Regulatory Authorities

Pharmacovigilance Regulations in the Philippines

  • Introduction to Pharmacovigilance in the Philippines and Legal Basis
  • Pharmacovigilance system
    • QPPV
    • Records of PV
  • Reporting of Adverse Reactions
    • Timeframes, Reporting requirements
  • Significant safety Information
  • Risk Management Plan (RMP)
    • Submission requirements, Documents, Risk Minimisation activities
  • Periodic Benefit-Risk Evaluation (PBRERs)
    • Reporting requirements, Format & contents
  • Actions taken by other national drug authorities
  • PV inspections

Enrol or reserve

Raphael Tian
Accestra Consulting

Pharmacovigilance Manager at Accestra Consulting

Mr. Raphael Tian is a seasoned pharmacovigilance Manager at Accestra Consulting, with extensive experience in top global pharmaceutical companies and a focus on the Chinese market. With hands-on experience in Adverse Event monitoring and reporting, Literature screening, Research Related Programs, Market Research and Patient Support Programs, PV agreements, Chinese GVP, and local regulations. Raphael is an experienced trainer in pharmacovigilance with a strong communication network in the local and global pharmaceutical industry in China. To learn more about Raphael or Accestra Consulting, please visit www.accestra.com.

 

More details

Marylene Zhan
Accestra Consulting

Senior consultant at Accestra Consulting

Ms. Marylene Zhan is a senior consultant at Accestra Consulting with extensive experience in pharmacovigilance and regulatory affairs, with a Master's Degree from the Zhongnan University of Economics and Law. Marylene is a seasoned bilingual and bicultural consultant who specialises in China regulatory compliance and pharmacovigilance services (RA/PV). She has a wealth of knowledge on Chinese Pharmaceutical regulations and in-depth insight into dealing with Chinese market access requirements. Marylene has a rich experience in serving international pharma companies with market entry into China, providing support in the areas of adverse event monitoring and reporting, literature screening, PV agreements, Chinese GVP and local regulations, SOP & PSMF writing, and more. To learn more about Marylene or Accestra Consulting, visit www.accestra.com.

More details

Helen Ye
Accestra Consulting

RA & PV Director at Accestra Consulting 

  • Ms. Ye has been dedicated to regulatory affairs consulting for 15 years with a Pharmacy degree from Zhejiang University, China. 
  • She is experienced in regulatory compliance of China market access & post-marketing maintenance of pharmaceutical products, providing insightful and customised solutions to international pharmaceutical companies and government institutions. 
  • She leads the registration team to plan, develop and implement compliance strategies for top pharma clients and has a successful track record for obtaining market approval for drug products, APIs, Excipients, Packaging Materials, medical devices and other products.
  • Ms. Ye has a strong communication network with Chinese authorities (e.g. NMPA and CDE) and industry experts in China. 
  • To learn more about Helen or Accestra Consulting, please visit their website at www.accestra.com

More details

Priyanka Mangle
Pharma to Market

Pharmacovigilance Manager at Pharma To Market

Ms. Priyanka Mangle is a Pharmacist with Master’s degree in pharmacy and post-graduate diploma in clinical research. She is an experienced Pharmacovigilance professional with hands-on experience in Adverse event monitoring & reporting, Literature & Regulatory Intelligence screening, Market Research & Patient support programs, Safety Data Exchange Agreements/PV agreements, SOP & PSMF writing, RMPs. She has actively participated in multiple audits and inspections including US-FDA audit, MHRA inspection and have also conducted vendor/business partner audits in past. She has a wide experience in conducting Pharmacovigilance training for a variety of regions including APAC, LATAM. She has in-depth knowledge of end-to-end PV processes along with global and regional regulations specific to Pharmacovigilance. She is currently based in Malaysia, working as Pharmacovigilance Manager at Pharma To Market, handling various pharmaceutical clients, working as QPPV and managing Pharmacovigilance activities in APAC regions.

More details

Param Dayal
Pharma To Market

Drug Safety Manager at Pharma To Market

Mr. Param Dayal is a qualified Microbiologist with Master’s degree in Microbiology and a certified MedDRA coder. For the last 15 years, Param has worked on a variety of pharmacovigilance projects with special focus on ICSR processing (Unsolicited, solicited, Literature, legal and Clinical trials cases). In his previous roles he worked for organisations supporting pharma clients with PSP program management, PV audits, HA inspections, data migration, SOP Management, process refinement, providing PV training and mentoring to new staff. He also has experience working as a QPPV and Local Safety Officer for Australia and New Zealand. He is currently based in Melbourne working as Drug Safety Manager for Pharma To Market, managing PV activities for NZ clients.

 

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

8-9 July 2024

Live online

09:30-12:30 UK (London) (UTC+01)
10:30-13:30 Paris (UTC+02)
04:30-07:30 New York (UTC-04)
Course code 13850

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 03 Jun

View basket 

 
Not ready to book yet?

for 7 days, no obligation

8-9 October 2024

Live online

09:30-12:30 UK (London) (UTC+01)
10:30-13:30 Paris (UTC+02)
04:30-07:30 New York (UTC-04)
Course code 13993

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 03 Sep

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Singapore

  • Labgistics Asia Pte Ltd
  • LUNDBECK SINGAPORE PTE. LTD.

Enrol or reserve

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Yesim NURKO
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy